乳房重建市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

乳房重建市场按最终用户和地理位置按产品(乳房植入物、组织扩张器、脱细胞真皮基质等)进行细分。

乳房重建市场快照

Breast Reconstruction Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.1 %
Breast Reconstruction Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

所研究的乳房再造市场预计在预测期内将以近 7.1% 的复合年增长率增长。导致市场增长的主要因素是乳腺癌发病率的增加。根据世界卫生组织的数据,乳腺癌是女性中最常见的癌症,每年影响 210 万女性,并且影响女性癌症相关死亡人数最多。2018 年,估计有 627,000 名女性死于乳腺癌。此外,提高对乳房重建选择安全性的认识正在使接受乳房切除术和其他乳腺癌手术的女性放心选择重建过程。具有先进技术的产品不断增加,正在推动市场增长。然而,

报告范围

根据报告的范围,乳房再造是一种外科手术,可在切除乳房以治疗或预防乳腺癌的手术后恢复乳房的形状。此报告按产品、最终用户和地理位置细分。

By Product
Breast Implants
Tissue Expanders
Acellular Dermal Matrices
Other
By End-User
Hospitals
Ambulatory Care Centers
Other
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

乳房植入物在乳房重建市场中占有最大份额。

  • 乳房再造手术中乳房植入物占全球市场的主要份额,预计在预测期内这仍将是乳房再造领域的一个突出趋势。植入物是盐水或硅胶植入物。
  • 与乳腺癌发病率增长成正比的乳房手术数量的增加正在推动细分市场的增长。根据国际美容整形外科学会的数据,2017 年进行了 1540289 例涉及植入物的隆胸手术。随着手术数量的增加,该细分市场的增长也在增加。
  • 因此,考虑到上述所有因素,预计市场将在预测期内实现高速增长。
Breast Reconstruction Market Trends

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个市场。市场增长是由于乳腺癌发病率高和隆胸手术增加等因素,成熟的医疗保健基础设施是其在市场上占有很大份额的一些关键因素。根据美国癌症协会的数据,2017 年,估计有 252,710 例新的浸润性乳腺癌病例在女性中被诊断出来。此外,有益的政府举措和研究合作伙伴数量的增加是预计增加市场增长的一些驱动因素。美国市场参与者日益关注的焦点和乳腺癌患病率的增加可能会推动北美乳房重建市场的增长。

Breast Reconstruction Market Growth

竞争格局

乳房再造市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司包括 Allergan、Sientra, Inc、IDEAL IMPLANT INCORPORATED、强生、Establishment Labs SA、POLYTECH Health & Aesthetics GmbH、RTI Surgical, Inc.、Groupe Sebbin SAS、Integra LifeSciences、GC Aesthetics .

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Breast Cancer

      2. 4.2.2 Introduction of Technologically Advanced Products

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Breast Reconstruction Procedures

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Breast Implants

      2. 5.1.2 Tissue Expanders

      3. 5.1.3 Acellular Dermal Matrices

      4. 5.1.4 Other

    2. 5.2 By End-User

      1. 5.2.1 Hospitals

      2. 5.2.2 Ambulatory Care Centers

      3. 5.2.3 Other

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan Plc

      2. 6.1.2 Sientra, Inc

      3. 6.1.3 IDEAL IMPLANT INCORPORATED

      4. 6.1.4 Johnson & Johnson

      5. 6.1.5 Establishment Labs S.A.

      6. 6.1.6 POLYTECH Health & Aesthetics GmbH

      7. 6.1.7 RTI Surgical, Inc.

      8. 6.1.8 Groupe Sebbin SAS

      9. 6.1.9 Integra LifeSciences

      10. 6.1.10 GC Aesthetics

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Breast Reconstruction Market market is studied from 2018 - 2026.

The Breast Reconstruction Market is growing at a CAGR of 7.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Allergan Plc, Sientra, Inc, IDEAL IMPLANT INCORPORATED, Johnson & Johnson, Establishment Labs S.A. are the major companies operating in Breast Reconstruction Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!